- Home
- SSKN vs MYNZ Comparison
SSKN vs MYNZ Comparison
Compare SSKN & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSKN
- MYNZ
- Stock Information
- Founded
- SSKN 1989
- MYNZ 2021
- Country
- SSKN United States
- MYNZ Germany
- Employees
- SSKN N/A
- MYNZ N/A
- Industry
- SSKN Medical/Dental Instruments
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- SSKN Health Care
- MYNZ Health Care
- Exchange
- SSKN Nasdaq
- MYNZ Nasdaq
- Market Cap
- SSKN 10.6M
- MYNZ 10.5M
- IPO Year
- SSKN 2005
- MYNZ 2021
- Fundamental
- Price
- SSKN $2.70
- MYNZ $2.93
- Analyst Decision
- SSKN Strong Buy
- MYNZ Buy
- Analyst Count
- SSKN 1
- MYNZ 3
- Target Price
- SSKN $6.00
- MYNZ $14.00
- AVG Volume (30 Days)
- SSKN 3.9K
- MYNZ 174.9K
- Earning Date
- SSKN 03-27-2025
- MYNZ 04-15-2025
- Dividend Yield
- SSKN N/A
- MYNZ N/A
- EPS Growth
- SSKN N/A
- MYNZ N/A
- EPS
- SSKN N/A
- MYNZ N/A
- Revenue
- SSKN $33,562,000.00
- MYNZ $917,203.00
- Revenue This Year
- SSKN $0.79
- MYNZ $20.94
- Revenue Next Year
- SSKN $8.17
- MYNZ $18.01
- P/E Ratio
- SSKN N/A
- MYNZ N/A
- Revenue Growth
- SSKN 0.61
- MYNZ 16.23
- 52 Week Low
- SSKN $2.51
- MYNZ $0.18
- 52 Week High
- SSKN $5.90
- MYNZ $8.20
- Technical
- Relative Strength Index (RSI)
- SSKN 50.18
- MYNZ 34.37
- Support Level
- SSKN $2.53
- MYNZ $2.88
- Resistance Level
- SSKN $2.72
- MYNZ $5.34
- Average True Range (ATR)
- SSKN 0.13
- MYNZ 0.50
- MACD
- SSKN 0.01
- MYNZ -0.11
- Stochastic Oscillator
- SSKN 63.33
- MYNZ 19.84
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.